In this issue:
Bladder cancer risk not increase by pioglitazone
BP and complications in type 2 diabetes with no prior CV disease
Socioeconomic status and mortality in type 2 diabetes
Low birthweight and type 2 diabetes risk
Transdermal buprenorphine relieves neuropathic pain
Liraglutide vs. lixisenatide added to metformin in type 2 diabetes
AZP-531, a first-in-class unacylated ghrelin analogue
Treatment intensification for type 2 diabetes with poor glycaemic control
Phytosterol spread improves lipids and insulin resistance in gestational diabetes
Delayed-release metformin: better efficacy with less plasma exposure?
Please login below to download this issue (PDF)